News and Stories | Arnold Ventures

Research Into Student Success Programs

Podcast: Taxpayers Are Writing a Blank Check to Higher Education. We Should be Getting More for Our Money. Deep Dive with Laura Arnold

Criminal Justice

Celebrating 10 Years of National Network for Safe Communities

T.R.U.E. mentees and Dannel Malloy

Leading Prison Reform from the Inside Transforming Prisons

Cross-Border Drug Runs, Deadly Rationing and Black Market Sales Define Life of a Type 1 Diabetes Patient

A hospital room

Commercial Sector Prices

Nationwide Claims Database Could Shed Light on Secret Hospital Prices

Commercial Sector Prices

Texas Is Latest State To Attack Surprise Medical Bills

Commercial Sector Prices

A Year After Spinal Surgery, $94,031 Bill Feels Like a Back-Breaker

Community Supervision

From Tripwire to Lifeline: Reforming a Broken Probation and Parole System Q&A

Research on Gun Violence National Collaborative on Gun Violence Research Advisory Committee Selects Projects for First Funding Round

Judicial Release Decisions

How New Orleans Can Stop Using Its Most Vulnerable Residents to Fund Courts Q&A

The “Expression Room” in the T.R.U.E. unit

Thinking Beyond the Prison Cell Transforming Prisons

An injection of insulin

New Study Addresses Vast Price Disparities Between Drugs in the U.S., Other Nations Q&A

Contraceptive Choice & Access

Pain Relievers, Cold Medicine — and The Pill

Transparency is Just One Piece of the Drug Pricing Puzzle

Community Supervision

Podcast: Meek Mill on Probation and Parole in America Deep Dive with Laura Arnold

Poll Reveals Near-Unanimous Call for Aggressive Congressional Action to Lower Prescription Drug Prices

Walmart Charts New Course By Steering Workers To High-Quality Imaging Centers

Prisons Small, Safe, and Humane: A Vision for Prison Reform

Shining a Light Inside Prisons Transforming Prisons

Civica Rx Set to Deliver Essential Antibiotics to Hundreds of Hospitals

The Opioid Epidemic

Jails Could Be a Turning Point in the Opioid Crisis

Arnold: ‘Independent Body, Not the Payer or Drug Company, Should Decide the Value of a Drug’

Drug Industry Patents Go Under Senate Judiciary Committee’s Microscope

Commercial Sector Prices

‘Medicare for All’ Debate Is An Opportunity to Address High Prices